Efficacy News and Research

RSS
Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Viruses modify host cellular machinery to produce high amounts of viral progeny

Viruses modify host cellular machinery to produce high amounts of viral progeny

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

What is the impact of the SARS-CoV-2 omicron wave in South Africa?

What is the impact of the SARS-CoV-2 omicron wave in South Africa?

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Novavax COVID-19 vaccine granted UK approval for 12- to 17-year-olds by MHRA

Novavax COVID-19 vaccine granted UK approval for 12- to 17-year-olds by MHRA

Durable coating may soon be a new weapon in the fight against germs

Durable coating may soon be a new weapon in the fight against germs

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

New study investigates a potential treatment for people diagnosed with monkeypox

New study investigates a potential treatment for people diagnosed with monkeypox

What is the efficacy of Grignard Pure™ against surrogate of SARS-CoV-2?

What is the efficacy of Grignard Pure™ against surrogate of SARS-CoV-2?

What is the link between influenza vaccination and the severity of COVID-19 infection?

What is the link between influenza vaccination and the severity of COVID-19 infection?

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.